Literature DB >> 2802191

Thoracic epidural anesthesia and central hemodynamics in patients with unstable angina pectoris.

S Blomberg1, H Emanuelsson, S E Ricksten.   

Abstract

The effects of high thoracic epidural anesthesia (TEA) on central hemodynamics as measured by pulmonary arterial catheterization were studied in nine patients with severe coronary artery disease and unstable angina pectoris. The patients were also treated with a combination of beta-blockers, calcium antagonists, and nitrates, as well as salicylates, low-dose heparin, and nitroglycerin infusion for greater than 24 hr. Management of pain with high TEA was started with the bolus epidural injection of 4.3 +/- 0.2 mL bupivacaine (5 mg/mL), which induced a sympathetic blockade from Th. During ischemic chest pain, pulmonary artery and pulmonary capillary wedge pressures were significantly increased. TEA, while relieving the chest pain, significantly decreased systolic arterial blood pressure, heart rate, and pulmonary artery and pulmonary capillary wedge pressures, without any significant changes in coronary perfusion pressure, cardiac output, stroke volume, and systemic or pulmonary vascular resistances. In some patients, ST-segment depression was less pronounced during TEA. Thus, during ischemic chest pain, TEA has beneficial effects on the major determinants of myocardial oxygen consumption, without jeopardizing coronary perfusion pressure. TEA may therefore favorably alter the oxygen supply/demand ratio within ischemic myocardial areas.

Entities:  

Mesh:

Year:  1989        PMID: 2802191

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  15 in total

1.  A prospective randomized study of intraoperative thoracic epidural analgesia in off-pump coronary artery bypass surgery.

Authors:  Yongxin Liang; Haichen Chu; Hua Zhen; Shiduan Wang; Miaoning Gu
Journal:  J Anesth       Date:  2012-01-25       Impact factor: 2.078

2.  Association of thoracic epidural analgesia with risk of atrial arrhythmias after pulmonary resection: a retrospective cohort study.

Authors:  Ryu Komatsu; Natalya Makarova; Jarrod E Dalton; Zhuo Sun; Dennis Chang; Radhika Grandhe; Roshni Sreedharan; Karine De Oliveira Dias; Rakhi Pal; Allen Bashour; Sudish C Murthy; Alparslan Turan
Journal:  J Anesth       Date:  2014-06-24       Impact factor: 2.078

3.  High thoracic epidural anesthesia in cardiac surgery: risk factors for arterial hypotension.

Authors:  Stefano Casalino; Fabio Mangia; Edmond Stelian; Eugenio Novelli; Marco Diena; Ugo F Tesler
Journal:  Tex Heart Inst J       Date:  2006

Review 4.  Pain relief following cardiac surgery: a review.

Authors:  A Taylor; D Phelan; J R McCarthy
Journal:  Ir J Med Sci       Date:  1996 Jan-Mar       Impact factor: 1.568

5.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 6.  Ultra-minimally invasive cardiac surgery: robotic surgery and awake CABG.

Authors:  Norihiko Ishikawa; Go Watanabe
Journal:  Surg Today       Date:  2014-10-02       Impact factor: 2.549

7.  Thoracic epidural blockade preserves left ventricular early diastolic filling assessed by transesophageal echocardiography.

Authors:  Toshiya Shiga
Journal:  J Anesth       Date:  1998-03       Impact factor: 2.078

8.  Epidural morphine reduces the risk of postoperative myocardial ischaemia in patients with cardiac risk factors.

Authors:  W S Beattie; D N Buckley; J B Forrest
Journal:  Can J Anaesth       Date:  1993-06       Impact factor: 5.063

9.  [Influence of postoperative pain on morbidity and mortality.].

Authors:  W Seeling; M Rockemann
Journal:  Schmerz       Date:  1993-06       Impact factor: 1.107

10.  Serial Peak Expiratory Flow Rates in Patients Undergoing Upper Abdominal Surgeries Under General Anaesthesia and Thoracic Epidural Analgesia.

Authors:  Julie C R Misquith; Rammoorthi Rao; Karl Sa Ribeiro
Journal:  J Clin Diagn Res       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.